-
EP3463436
European procedure
Extract from the Register of European Patents
EP About this file: EP3463436
| EP3463436 - A VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN TREATING CANCER [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.07.2024 Database last updated on 02.11.2024 | |
| Former | The patent has been granted Status updated on 18.08.2023 | ||
| Former | Grant of patent is intended Status updated on 12.04.2023 | ||
| Former | Examination is in progress Status updated on 24.03.2020 | ||
| Former | Request for examination was made Status updated on 08.03.2019 | ||
| Former | The international publication has been made Status updated on 08.12.2017 | ||
| Former | unknown Status updated on 21.06.2017 | Most recent event Tooltip | 26.07.2024 | No opposition filed within time limit | published on 28.08.2024 [2024/35] | Applicant(s) | For all designated states Ultimovacs ASA Ullernchausséen 64 0379 Oslo / NO | [2019/48] |
| Former [2019/15] | For all designated states Ultimovacs AS Ullernchausséen 64 0379 Oslo / NO | Inventor(s) | 01 /
GAUDERNACK, Gustav Anthon Walles vei 17 A 1337 Sandvika / NO | 02 /
TORNES, Audun Konglefaret 22 3021 Drammen / NO | [2019/15] | Representative(s) | Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB | [2023/38] |
| Former [2019/15] | Arends, William Gerrit Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 17729078.0 | 02.06.2017 | [2019/15] | WO2017EP63589 | Priority number, date | EP20160172760 | 02.06.2016 Original published format: EP 16172760 | [2019/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017207814 | Date: | 07.12.2017 | Language: | EN | [2017/49] | Type: | A1 Application with search report | No.: | EP3463436 | Date: | 10.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.12.2017 takes the place of the publication of the European patent application. | [2019/15] | Type: | B1 Patent specification | No.: | EP3463436 | Date: | 20.09.2023 | Language: | EN | [2023/38] | Search report(s) | International search report - published on: | EP | 07.12.2017 | Classification | IPC: | A61K39/00, C07K16/28 | [2019/15] | CPC: |
A61K39/0011 (EP,US);
A61K39/00115 (EP,US);
A61K39/001154 (EP,US);
A61K39/001157 (EP,US);
A61K39/39558 (EP,US);
A61P35/00 (EP,US);
A61P35/04 (EP,US);
C07K16/2818 (EP,US);
A61K2039/505 (EP,US);
A61K2039/53 (EP,US);
A61K2039/70 (EP,US);
C07K2317/21 (EP,US);
C07K2317/76 (EP,US)
(-)
| C-Set: |
A61K39/0011, A61K2300/00 (EP,US);
A61K39/39558, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/15] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | IMPFSTOFF IN KOMBINATION MIT EINEN ANTAGONIST EINES IMMUN-CHECKPOINT-HEMMERS ZUR VERWENDUNG IN DER KREBSBEHANDLUNG | [2023/14] | English: | A VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN TREATING CANCER | [2019/15] | French: | UN VACCIN EN COMBINAISON AVEC UN INHIBITEUR DE POINT DE CONTRÔLE IMMUNITAIRE POUR LE TRAITEMENT DE CANCER | [2023/19] |
| Former [2019/15] | IMPFSTOFF IN KOMBINATION MIT EINEM IMMUN-CHECKPOINT-INHIBITOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS | ||
| Former [2019/15] | VACCIN À UTILISER EN COMBINAISON AVEC UN INHIBITEUR DU POINT DE CONTRÔLE IMMUNITAIRE POUR LE TRAITEMENT DU CANCER | Entry into regional phase | 02.01.2019 | National basic fee paid | 02.01.2019 | Designation fee(s) paid | 02.01.2019 | Examination fee paid | Examination procedure | 03.04.2018 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 02.01.2019 | Examination requested [2019/15] | 02.01.2019 | Date on which the examining division has become responsible | 05.08.2019 | Amendment by applicant (claims and/or description) | 27.03.2020 | Despatch of a communication from the examining division (Time limit: M07) | 06.10.2020 | Reply to a communication from the examining division | 12.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 06.01.2023 | Reply to a communication from the examining division | 13.04.2023 | Communication of intention to grant the patent | 09.08.2023 | Fee for grant paid | 09.08.2023 | Fee for publishing/printing paid | 09.08.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP23178501.5 / EP4253419 | Opposition(s) | 21.06.2024 | No opposition filed within time limit [2024/35] | Fees paid | Renewal fee | 13.06.2019 | Renewal fee patent year 03 | 31.03.2020 | Renewal fee patent year 04 | 14.06.2021 | Renewal fee patent year 05 | 31.03.2022 | Renewal fee patent year 06 | 31.03.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 20.09.2023 | [2024/20] | Cited in | International search | [Y]WO03086459 (MEDAREX INC [US], et al); | [X]WO2007113648 (PFIZER PROD INC [US], et al); | [Y]WO2011101173 (OSLO UNIVERSITY HOSPITAL HF [NO], et al); | [YD]WO2015095811 (BOARD INST INC [US], et al); | by applicant | WO03086459 | WO2007113648 | WO2011101173 | WO2015033140 | WO2015095811 | WO2015096811 | WO2016025647 |